2015 annual financial data
Celldex Therapeutics 2015 Operating margin
Direct answer
Operating margin was -2,363.89%.
Operating income was -129,541,000 USD and net income was -127,197,000 USD.
Operating cash flow was -98,887,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,480,000 USD
- Operating income
- -129,541,000 USD
- Net income
- -127,197,000 USD
- Operating cash flow
- -98,887,000 USD